RecruitingNot ApplicableNCT05115890

Muscle Blood Flow Regulation in HFpEF

Mechanisms of Impaired Skeletal Muscle Blood Flow and Exercise Intolerance in Veterans With Heart Failure With Preserved Ejection Fraction: Efficacy of Knee Extensor Training


Sponsor

VA Office of Research and Development

Enrollment

35 participants

Start Date

Jul 1, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

Heart failure with preserved ejection (HFpEF) disproportionately affects Veterans and is the number one reason for hospital discharge in the VA Health Care System. Exercise intolerance is a common complication experienced by patients with HFpEF, perpetuating physical inactivity and accelerating disease progression. This research proposal aims to elucidate mechanisms responsible for inadequate skeletal muscle blood flow and exercise intolerance in patients with HFpEF compared with healthy controls as well as following 8 weeks of exercise training in patients with HFpEF only.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating why people with heart failure with preserved ejection fraction (HFpEF) — a type of heart failure where the heart pumps normally but is too stiff — have poor exercise tolerance. Specifically, it looks at whether blood flow to muscles during exercise is impaired and what role the nervous system plays. Understanding this could lead to better treatments. **You may be eligible if...** - You are 18 or older with diagnosed HFpEF (heart failure where the pumping fraction is above 50%) - You are in NYHA class II or III (meaning you have symptoms during moderate or mild activity) - Your BNP or NT-proBNP levels are elevated (a blood marker of heart stress) - You are stable on your current heart medications **You may NOT be eligible if...** - Your heart pumping fraction has ever been below 50% - You have NYHA class IV heart failure (symptoms at rest) that cannot be stabilized - You have had a recent heart attack, myocarditis, or have a condition like cardiac sarcoidosis - You have an orthopedic problem that prevents you from doing leg exercises - You are a woman taking hormone replacement therapy or currently pregnant - You are a current smoker Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERExercise training

Patients with HFpEF will undergo 8 weeks of exercise training.


Locations(1)

VA Salt Lake City Health Care System, Salt Lake City, UT

Salt Lake City, Utah, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05115890


Related Trials